Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices 51877 

Basic class 

2018 

Established 

quotas 

(g) 

Methamphetamine ............................................................................................................................................................................... 1,446,754 

[846,000 grams of levo-desoxyephedrine for use in a non-controlled, non-prescription product; 564,000 grams for methamphetamine mostly for 

conversion to a schedule III product; and 36,754 grams for methamphetamine (for sale)] 

Methylphenidate ................................................................................................................................................................................... 64,600,000 

Morphine (for conversion) .................................................................................................................................................................... 4,089,000 

Morphine (for sale) .............................................................................................................................................................................. 33,958,440 

Nabilone ............................................................................................................................................................................................... 31,000 

Noroxymorphone (for conversion) ....................................................................................................................................................... 14,044,540 

Noroxymorphone (for sale) .................................................................................................................................................................. 376,000 

Opium (powder) ................................................................................................................................................................................... 84,600 

Opium (tincture) ................................................................................................................................................................................... 564,000 

Oripavine .............................................................................................................................................................................................. 24,534,000 

Oxycodone (for conversion) ................................................................................................................................................................ 2,453,400 

Oxycodone (for sale) ........................................................................................................................................................................... 95,692,000 

Oxymorphone (for conversion) ............................................................................................................................................................ 20,962,000 

Oxymorphone (for sale) ....................................................................................................................................................................... 3,395,280 

Pentobarbital ........................................................................................................................................................................................ 25,850,000 

Phenazocine ........................................................................................................................................................................................ 5 

Phencyclidine ....................................................................................................................................................................................... 35 

Phenmetrazine ..................................................................................................................................................................................... 25 

Phenylacetone ..................................................................................................................................................................................... 40 

Racemethorphan ................................................................................................................................................................................. 5 

Racemorphan ...................................................................................................................................................................................... 5 

Remifentanil ......................................................................................................................................................................................... 2,820 

Secobarbital ......................................................................................................................................................................................... 161,682 

Sufentanil ............................................................................................................................................................................................. 1,880 

Tapentadol ........................................................................................................................................................................................... 18,388,280 

Thebaine .............................................................................................................................................................................................. 94,000,000 

List I Chemicals 

Ephedrine (for conversion) .................................................................................................................................................................. 47,000 

Ephedrine (for sale) ............................................................................................................................................................................. 4,136,000 

Phenylpropanolamine (for conversion) ................................................................................................................................................ 14,100,000 

Phenylpropanolamine (for sale) ........................................................................................................................................................... 7,990,000 

Pseudoephedrine (for conversion) ...................................................................................................................................................... 40 

Pseudoephedrine (for sale) ................................................................................................................................................................. 180,000,000 

The Administrator also establishes 

aggregate production quotas for all other 

schedule I and II controlled substances 

included in 21 CFR 1308.11 and 

1308.12 at zero. In accordance with 21 

CFR 1303.13 and 21 CFR 1315.13, upon 

consideration of the relevant factors, the 

Administrator may adjust the 2018 

aggregate production quotas and 

assessment of annual needs as needed. 

Dated: November 1, 2017. 

Robert W. Patterson, 

Acting Administrator. 

[FR Doc. 2017–24306 Filed 11–7–17; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Foreign Claims Settlement 

Commission 

[F.C.S.C. Meeting and Hearing Notice No. 

10–17] 

Sunshine Act Meeting 

The Foreign Claims Settlement 

Commission, pursuant to its regulations 

(45 CFR part 503.25) and the 

Government in the Sunshine Act (5 

U.S.C. 552b), hereby gives notice in 

regard to the scheduling of open 

meetings as follows: 

THURSDAY, NOVEMBER 16, 2017: 10:00 

a.m.—Issuance of Proposed Decisions in 

claims against Iraq. 

STATUS: Open. 

All meetings are held at the Foreign 

Claims Settlement Commission, 600 E 

Street NW., Washington, DC. Requests 

for information, or advance notices of 

intention to observe an open meeting, 

may be directed to: Patricia M. Hall, 

Foreign Claims Settlement Commission, 

600 E Street NW., Suite 6002, 

Washington, DC 20579. Telephone: 

(202) 616–6975. 

Brian M. Simkin, 

Chief Counsel. 

[FR Doc. 2017–24361 Filed 11–6–17; 8:45 am] 

BILLING CODE 4410–BA–P 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree Under the Clean Air 

Act 

On October 31, 2017, the Department 

of Justice lodged a proposed consent 

decree with the United States District 

Court for the District of Colorado in the 

lawsuit entitled United States of 

America and the State of Colorado v. 

PDC Energy, Inc., Civil Action No. 1:17– 

cv–01552–MSK–MJW. 

The lawsuit seeks injunctive relief 

and civil penalties for violations of the 

Clean Air Act, the Colorado Air 


ethrower on DSK3G9T082PROD with NOTICES
51878 Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices 

Pollution Prevention and Control Act 

(‘‘Colorado Act’’), Colorado’s federally 

approved State Implementation Plan 

(‘‘Colorado SIP’’), and Colorado Air 

Quality Control Commission Regulation 

Number 7 (‘‘Regulation No. 7’’) at tank 

batteries (referred to in the consent 

decree as ‘‘Tank Systems’’) owned and 

operated by PDC Energy, Inc. (‘‘PDC’’) in 

a portion of the Denver-Julesburg Basin 

in Colorado (known as the ‘‘8-hour 

Ozone Control Area’’) designated as 

non-attainment with the National 

Ambient Air Quality Standards for 

ground-level ozone. The violations 

relate to alleged failures to adequately 

design, operate, and maintain vapor 

control systems at the Tank Systems, 

resulting in emissions of volatile organic 

compounds (‘‘VOC’’) and other 

pollutants to the atmosphere. 

The proposed consent decree covers 

PDC’s Tank Systems in the 8-hour 

Ozone Control Area equipped with 

vapor control systems pursuant to 

Regulation No. 7 to achieve required 

system-wide emission reductions (more 

than 600 Tank Systems). The proposed 

decree requires PDC to perform 

injunctive relief, including conducting 

engineering evaluations of the vapor 

control systems at each of the Tank 

Systems and completing any necessary 

corrective actions to ensure that the 

vapor control systems are adequately 

designed and sized. PDC must also 

complete two environmental mitigation 

projects at a cost of $1.7 million and pay 

a $2.5 million civil penalty, $1 million 

of which is anticipated to be used to 

perform one or more State-Only 

Supplemental Environmental Projects. 

Entering into and fully complying with 

the proposed consent decree will release 

PDC from past civil liability at the Tank 

Systems and associated vapor control 

systems for violations of the Colorado 

SIP and Regulation No. 7 relating to 

VOC emissions from condensate storage 

tanks. 

The publication of this notice opens 

a period for public comment on the 

consent decree. Comments should be 

addressed to the Assistant Attorney 

General, Environment and Natural 

Resources Division, and should refer to 

United States, et al. v. PDC Energy, Inc., 

D.J. Ref. No. 90–5–2–1–11467. All 

comments must be submitted no later 

than thirty (30) days after the 

publication date of this notice. 

Comments may be submitted either by 

email or by mail: 

To submit 

comments: Send them to: 

By email ......... pubcomment-ees.enrd@

usdoj.gov. 

To submit 

comments: Send them to: 

By mail ........... Assistant Attorney General, 

U.S. DOJ—ENRD, P.O. 

Box 7611, Washington, 

D.C. 20044–7611. 

During the public comment period, 

the consent decree may be examined 

and downloaded at this Justice 

Department Web site: https://

www.justice.gov/enrd/consent-decrees. 

We will provide a paper copy of the 

consent decree upon written request 

and payment of reproduction costs. 

Please mail your request and payment 

to: Consent Decree Library, U.S. DOJ— 

ENRD, P.O. Box 7611, Washington, DC 

20044–7611. 

Please enclose a check or money order 

for $25.25 (25 cents per page 

reproduction cost) payable to the United 

States Treasury. 

Jeffrey Sands, 

Assistant Section Chief, Environmental 

Enforcement Section, Environment and 

Natural Resources Division. 

[FR Doc. 2017–24250 Filed 11–7–17; 8:45 am] 

BILLING CODE 4410–15–P 

NATIONAL SCIENCE FOUNDATION 

Notice of Availability and Notice of 

Public Meeting for the Draft 

Environmental Impact Statement 

(DEIS) for the Green Bank 

Observatory, Green Bank, West 

Virginia 

AGENCY: National Science Foundation. 

ACTION: Notice of availability and notice 

of public meeting. 

SUMMARY: The National Science 

Foundation (NSF) has made available 

for public review and comment the 

Draft Environmental Impact Statement 

(DEIS) for Green Bank Observatory. This 

DEIS has been prepared for the National 

Science Foundation (NSF) to evaluate 

the potential environmental impacts 

resulting from proposed operational 

changes due to funding constraints for 

the Green Bank Observatory in Green 

Bank, West Virginia. The DEIS was 

prepared in compliance with the 

National Environmental Policy Act of 

1969. Consultation under Section 106 of 

the National Historic Preservation Act 

(NHPA) is being conducted concurrent 

with the NEPA process. 

DATES: NSF will accept comments on 

the DEIS for 60 days following 

publication of this Notice of 

Availability; an additional 15 days are 

being provided beyond the standard 45- 

day review period to allow for the 

holidays). Comments may be submitted 

verbally during the public meeting 

scheduled for November 30, 2017 (see 

details in SUPPLEMENTARY INFORMATION) 

or in writing until January 8th, 2018. 

Substantive comments will be 

addressed in a Final Environmental 

Impact Statement (FEIS). 

ADDRESSES: You may submit written 

comments by either of the following 

methods: 

• Email to: envcomp-ASTgreenbank@nsf.gov, with subject line 

‘‘Green Bank Observatory’’. 

• Mail to: Elizabeth Pentecost, RE: 

Green Bank Observatory, National 

Science Foundation, 2415 Eisenhower 

Avenue, Suite W9152, Alexandria, VA 

22314. 

FOR FURTHER INFORMATION CONTACT: For 

further information regarding the EIS 

process or Section 106 consultation, 

contact: Elizabeth Pentecost, National 

Science Foundation, Division of 

Astronomical Sciences, 2415 

Eisenhower Avenue, Suite W9152, 

Alexandria, VA 22314; telephone: (703) 

292–4907; email: epenteco@nsf.gov. 

DEIS Information: The DEIS, as well 

as information about the public meeting, 

is posted at www.nsf.gov/AST. A copy 

of the DEIS will be available for review 

at the following libraries: Green Bank 

Public Library, 5683 Potomac Highlands 

Trail, Green Bank, WV 24944, Durbin 

Community Library, 4361 Staunton 

Parkersburg Turnpike, Durbin, WV 

26264. 

SUPPLEMENTARY INFORMATION: Green 

Bank Observatory (GBO) is located in 

Pocahontas County, West Virginia, 

adjacent to the Monongahela National 

Forest. NSF owns the GBO land, which 

consists of numerous parcels acquired 

by the U.S. Army Corps of Engineers in 

the 1950s, when GBO was formed as the 

first (and then, only) site of the National 

Radio Astronomy Observatory (NRAO). 

The GBO facilities include the Robert C. 

Byrd Green Bank Telescope, the largest 

fully steerable radio telescope in the 

world; the 43-meter Telescope; the 

Green Bank Solar Radio Burst 

Spectrometer; the 20-meter Geodetic 

Telescope; the 40-foot Telescope; the 

Interferometer Range; and previously 

operational telescopes. 

The NSF Directorate for Mathematical 

and Physical Sciences, Division of 

Astronomical Sciences (AST), through a 

series of academic community-based 

reviews, has identified the need to 

divest several facilities from its 

portfolio. This would allow NSF to 

retain the balance of capabilities needed 

to deliver the best performance on 

emerging and key science technology of 

the present decade and beyond. In 2012, 


ethrower on DSK3G9T082PROD with NOTICES